Regulatory update · April 9, 2026 advisory
Health Canada has issued a national public advisory telling consumers not to buy or use unauthorized injectable peptide drugs often marketed for anti-aging, bodybuilding, recovery, or wellness.
The advisory does not ban every peptide-based medicine. It targets unauthorized injectable products and stresses that “research use only” labelling does not make them safe or lawful for human use.
Which compounds did Health Canada name?
The examples include BPC-157, CJC-1295, DSIP, Epitalon, GHK-Cu, HCG, ipamorelin, KPV, melanotan I and II, MOTS-C, NAD+, SS-31, TB-500, and retatrutide. Health Canada says the list is not exhaustive.
The names matter because many appear on Canadian-facing retail websites or social feeds. But the advisory is about unauthorized products – not a claim that all molecules described as peptides have one status.
What makes the products risky?
Unauthorized drugs have not been assessed by Health Canada for safety, effectiveness, or quality. The agency warns that they may contain the wrong ingredient or concentration, contaminants, or unlisted substances. Injectable products can also cause infection, allergic reactions, drug interactions, and other serious adverse effects.
The research-use disclaimer is not a workaround
The advisory specifically tells Canadians not to use drugs labelled “For Research Use Only – Not for Human Consumption.” A label written by the seller is not market authorization and does not replace evidence about sterility, identity, potency, benefits, or harms.
How Canadians can verify a product
Authorized prescription drugs carry an eight-digit DIN. Search the exact number and product in Health Canada’s Drug Product Database, then match the manufacturer, ingredient, strength, route, status, and product monograph. A legitimate record for one finished product does not authorize a different vial using the same ingredient name.
What Health Canada recommends
- Do not buy or use unauthorized drugs.
- Use prescription drugs under a healthcare professional’s care and obtain them from a licensed pharmacy.
- If you used an unauthorized injectable peptide and feel unwell or have concerns, contact a healthcare professional.
- Use a local pharmacy or municipal guidance for proper disposal.
- Report suspected side effects or health-product complaints to Health Canada.
What publishers and consumers should learn
A peptide article should never collapse “promising research” into “available treatment.” It should show the exact Canadian status, the date checked, the kind of evidence available, and what remains unknown. Seller links, injection instructions, or guaranteed outcomes would pull readers in the opposite direction.
Read the full Health Canada advisory
Source trail